Tranexamic Acid Dosing for Pediatric Patients
For pediatric trauma with hemorrhage, administer tranexamic acid 15 mg/kg IV loading dose (maximum 1 g) followed by 2 mg/kg/hour infusion, given within 3 hours of injury. This represents the most evidence-based approach balancing efficacy and safety in children.
Intravenous Administration
Trauma and Hemorrhage
The recommended pediatric trauma dosing is:
- Loading dose: 15 mg/kg IV (maximum 1 g) over 10 minutes
- Maintenance infusion: 2 mg/kg/hour for up to 8 hours 1
This dosing must be initiated within 3 hours of injury to optimize benefit, as efficacy decreases by 10% for every 15-minute delay 2. Administration beyond 3 hours may be harmful and should be avoided.
FDA-Approved Dosing (Hemophilia/Dental Procedures)
For patients with hemophilia undergoing tooth extraction, the FDA-approved regimen is 3, 4:
- 10 mg/kg IV immediately before extraction (infuse no faster than 1 mL/minute to avoid hypotension)
- Post-procedure: 10 mg/kg IV 3-4 times daily for 2-8 days
Cardiac Surgery
For neonates and infants undergoing cardiac surgery with cardiopulmonary bypass, evidence supports the "10-10-4-4 rule" 5:
- Initial bolus: 10 mg/kg
- Infusion: 10 mg/kg/hour
- CPB prime: 4 mg/kg
- Post-CPB infusion: 4 mg/kg/hour
This maintains therapeutic concentrations above 20 μg/mL while avoiding seizure risk from excessive peak concentrations.
Perioperative Bleeding (General Surgery)
For non-cardiac pediatric surgery 6:
- Loading dose: 10-30 mg/kg
- Maintenance: 5-10 mg/kg/hour infusion
Oral Administration
The FDA label does not provide specific oral dosing for children. Oral tranexamic acid is primarily used in adults for menorrhagia and is not the standard route for acute pediatric hemorrhage management.
Critical Dosing Considerations
Renal Impairment
Dose adjustments are essential for renal dysfunction 4:
| Serum Creatinine | Dosing Adjustment |
|---|---|
| 1.36-2.83 mg/dL | 10 mg/kg twice daily |
| 2.83-5.66 mg/dL | 10 mg/kg once daily |
| >5.66 mg/dL | 10 mg/kg every 48 hours OR 5 mg/kg every 24 hours |
Age-Specific Pharmacokinetics
Neonates and young infants have distinct pharmacokinetic profiles requiring careful attention 5, 7:
- Clearance and volume of distribution vary significantly with postmenstrual age
- Cardiopulmonary bypass significantly impacts all pharmacokinetic parameters
- Weight-based dosing using allometric scaling is appropriate
Maximum Doses
While pediatric dosing is weight-based, practical maximum doses should be considered:
- Loading dose maximum: 1-2 g (depending on indication)
- Total daily dose: avoid exceeding 4 g due to increased thromboembolic risk (HR 5.33 at 4 g dose) 8
Alternative Routes
Nebulized Tranexamic Acid
For post-tonsillectomy hemorrhage and refractory epistaxis, nebulized TXA shows promise 9, 10:
- Typical concentration: 100 mg/mL (undiluted) or diluted to 10-50 mg/mL
- Applied topically during hemostasis or via nebulization
- Reduces need for invasive interventions
Safety Warnings
Contraindications
- Active intravascular clotting 3, 4
- Subarachnoid hemorrhage (risk of cerebral edema/infarction)
- Hypersensitivity to tranexamic acid
Critical Safety Points
- Route verification: IV ONLY—intrathecal administration causes seizures and cardiac arrhythmias 3, 4
- Timing window: Must give within 3 hours of trauma; potentially harmful after this window 2
- Infusion rate: No faster than 1 mL/minute to prevent hypotension 3, 4
- Thromboembolic risk: Avoid concomitant prothrombotic agents (Factor IX concentrates, hormonal contraceptives) 3, 4
Clinical Context
The evidence base for pediatric TXA remains limited compared to adults, with most recommendations extrapolated from adult data or small pediatric studies 11, 12, 9. Current practice shows significant variability:
- Only 35% of U.S. trauma centers use TXA in pediatric trauma 12
- Dosing ranges from 10-30 mg/kg loading dose across institutions
- Standardized pediatric-specific protocols are lacking 9
Common pitfall: Using adult fixed doses (1-2 g) without weight-based adjustment can lead to underdosing in larger children or overdosing in neonates. Always calculate weight-based doses with appropriate maximums.
The 15 mg/kg loading dose followed by 2 mg/kg/hour infusion represents the best balance of available evidence for trauma, supported by pharmacokinetic modeling 11 and guideline recommendations 1, while the FDA-approved 10 mg/kg dosing remains appropriate for hemophilia-related procedures 3, 4.